Page last updated: 2024-10-16

adenine and Tyrosinemias

adenine has been researched along with Tyrosinemias in 2 studies

Tyrosinemias: A group of disorders which have in common elevations of tyrosine in the blood and urine secondary to an enzyme deficiency. Type I tyrosinemia features episodic weakness, self-mutilation, hepatic necrosis, renal tubular injury, and seizures and is caused by a deficiency of the enzyme fumarylacetoacetase. Type II tyrosinemia features INTELLECTUAL DISABILITY, painful corneal ulcers, and keratoses of the palms and plantar surfaces and is caused by a deficiency of the enzyme TYROSINE TRANSAMINASE. Type III tyrosinemia features INTELLECTUAL DISABILITY and is caused by a deficiency of the enzyme 4-HYDROXYPHENYLPYRUVATE DIOXYGENASE. (Menkes, Textbook of Child Neurology, 5th ed, pp42-3)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Song, CQ1
Jiang, T1
Richter, M1
Rhym, LH1
Koblan, LW1
Zafra, MP1
Schatoff, EM1
Doman, JL1
Cao, Y1
Dow, LE1
Zhu, LJ1
Anderson, DG1
Liu, DR1
Yin, H1
Xue, W1
Musunuru, K1

Other Studies

2 other studies available for adenine and Tyrosinemias

ArticleYear
Adenine base editing in an adult mouse model of tyrosinaemia.
    Nature biomedical engineering, 2020, Volume: 4, Issue:1

    Topics: Adenine; Animals; Disease Models, Animal; Female; Gene Editing; HEK293 Cells; Hepatocytes; Humans; H

2020
Correcting tyrosinaemia via a point mutation.
    Nature biomedical engineering, 2020, Volume: 4, Issue:1

    Topics: Adenine; Animals; Mice; Point Mutation; Tyrosinemias

2020